Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors

Antithymocyte globulin (ATG) is widely used to reduce acute graft-versus-host disease (aGVHD) and chronic GVHD (cGVHD). To clarify the different impacts of ATG for conditioning across different donor types, we retrospectively analyzed patients with acute leukemia (n = 6617) who underwent hematopoiet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Wakamatsu, Manabu, Terakura, Seitaro, Ohashi, Kazuteru, Fukuda, Takahiro, Ozawa, Yukiyasu, Kanamori, Heiwa, Sawa, Masashi, Uchida, Naoyuki, Ota, Shuichi, Matsushita, Akiko, Kanda, Yoshinobu, Nakamae, Hirohisa, Ichinohe, Tatsuo, Kato, Koji, Murata, Makoto, Atsuta, Yoshiko, Teshima, Takanori
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2019
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6341193/
https://ncbi.nlm.nih.gov/pubmed/30626574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018025643
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars